Feltys Syndrome Sham A Cader Eugeniusz J Kucharz

  • Slides: 23
Download presentation
Felty’s Syndrome Sham A. Cader, Eugeniusz J. Kucharz Department Of Internal Medicine and Rheumatology

Felty’s Syndrome Sham A. Cader, Eugeniusz J. Kucharz Department Of Internal Medicine and Rheumatology Medical University Of Silesia Katowice - Poland

Felty’s syndrome represents one of many systemic complications of seropositive rheumatoid arthritis.

Felty’s syndrome represents one of many systemic complications of seropositive rheumatoid arthritis.

 • In 1924 by A. R Felty described the triad of chronic arthritis,

• In 1924 by A. R Felty described the triad of chronic arthritis, splenomegali and ganulocytopenia

Prevalence • The true prevalence of Felty’s syndrome is unknown, but it may be

Prevalence • The true prevalence of Felty’s syndrome is unknown, but it may be as high as 3 percent in seropositive rheumatoid arthritis patients. • In the US Felty’s syndrome affects approximately 1 -3% of all patients diagnosed with RA and RA occurs in about 1% of the general population.

Mortality and Morbidity • Although many patients are asymptomatic but others progress and develop

Mortality and Morbidity • Although many patients are asymptomatic but others progress and develop life-threatening infections. • Pulmonary and skin infections are common. • One study from the southwest of England observed 32 patients with Felty’s syndrome; 5 died from bronchopneumonia during a mean follow-up period of 5. 2 years. ( Bath Institute for Rheumatic Diseases, UK)

Race • • Felty’s syndrome most often occurs in whites and infrequently occurs in

Race • • Felty’s syndrome most often occurs in whites and infrequently occurs in blacks. The human leukocyte antigen DR 4 (HLA-DR 4) genotype, which is a marker for more aggressive RA and more frequent extraarticular manifestations in whites, is strongly associated with Felty’s syndrome. Also appear to be a DQ-linked susceptibility gene and a C 4 B-null allele that increase the risk of Felty’s syndrome. Incidence in women exceeds incidence in men by a ratio of 3: 1.

Pathogenesis • Mechanism for the development of granulocytopenia include accelerated removal of granulocytes from

Pathogenesis • Mechanism for the development of granulocytopenia include accelerated removal of granulocytes from the circulating pool and suppression of granulopoiesis. • Adherence of specific antibodies directed against granulocyte cell surface antigens, ingestion and surface-coating of immune complexes leads to impaired granucyte function and facilitates their removal by the reticularendothelial system.

 • Sequestration and margination of granulocytes in the spleen and venules in the

• Sequestration and margination of granulocytes in the spleen and venules in the lungs and elsewhere results in a diminished circulating pool. • Impaired production is caused by humoral or T cell suppression of myelopoiesis or inhibition of granulocyte growth factor production by cytokines. • A study performed in „Medizinische Universitat zu Lubeck” Germany, patients with Felty’s syndrome have auto antibodies against granulocyte colony-stimulating factor (G-CSF).

Clinical Features • Classic triad Chronic arthritis Active rheumatoid arthritis is present in about

Clinical Features • Classic triad Chronic arthritis Active rheumatoid arthritis is present in about 60% patients. ranges from mild involvement to severe deformity and erosion of the joints.

Splenomegaly Firm non tender spleen, ranges from nonpalpable (5 -10% of cases) to massive.

Splenomegaly Firm non tender spleen, ranges from nonpalpable (5 -10% of cases) to massive. There is no correlation between spleen size and the degree of leukopenia also mild hepatomegaly is common. Rare complications: splenic rupture, potal hypertension with esophageal verices.

Leukopenia • Recurrent serious infections in about 60% of patients; most common are skin

Leukopenia • Recurrent serious infections in about 60% of patients; most common are skin infections (abscesses, cellulitis, furunculosis) • The degree of leukopenia does not correlate well with number and severity of infections • Granulocytopenia may develop in just weeks and spontaneous remmisions are uncommon

Extra-Articular Manifestations • • Rheumatoid nodules (76%) Weight loss (68%) Sjögren’s Syndrome (56%) Lymphoadenopathy

Extra-Articular Manifestations • • Rheumatoid nodules (76%) Weight loss (68%) Sjögren’s Syndrome (56%) Lymphoadenopathy (34%) Leg ulcers (25%) Pleuritis (19%) Skin pigmentation (17%) – pulpable pupura and brownish pigmentary changes of the lower extremities. • Peripheral neuropathy (17%) • Episcleritis (8%)

Hematologic and Serologic features CBC • • • Granulocutopenia neutrophils usually between 1000 -

Hematologic and Serologic features CBC • • • Granulocutopenia neutrophils usually between 1000 - 2500/µL but can be <500/µL Lymphopenia in 33% Eosinophilia may be present in some Usually a lack of left shift and immature cells with a normal number of bands Anemia – mild-moderate normocytic normochromic anemia with an elevated reticulocyte count Thrombocytopenia – in 38% but seldom causes purpura

Composite of lymphocytes: 1 large granular lymphocyte (LGL) in top left frame, 1 large

Composite of lymphocytes: 1 large granular lymphocyte (LGL) in top left frame, 1 large lymphocyte in center frame, 3 medium lymphocytes in lower left and right frames. Normal blood - 100 X

Serum • High RF titre in 98% • ANA in 67% • Elevated ESR,

Serum • High RF titre in 98% • ANA in 67% • Elevated ESR, immunoglobulins, circulating immune complexes • Positive LE cell test in 33% • Decreased complement levels • Elevated transaminases and alkaline phosphatase in 25 -50%

Bone Marrow • Myeloid hyperplasia with a relative excess of immature forms (maturational arrest)

Bone Marrow • Myeloid hyperplasia with a relative excess of immature forms (maturational arrest) • Depressed myeloid activity or increased lymphocyte infiltration

 • This low-oil magnification view is of a bone marrow aspirate in a

• This low-oil magnification view is of a bone marrow aspirate in a patient with Felty's syndrome. Maturation arrest is at the metamyelocyte stage. There is significant reactive plasmocytosis (30%). A "Mott Cell" with grape-like inclusions is seen in the top center of the field

Liver Biopsy- Nodular Regenerative Hyperplasia

Liver Biopsy- Nodular Regenerative Hyperplasia

The pale tan discrete nodules of nodular regenerative hyperplasia have been mistaken for cirrhosis

The pale tan discrete nodules of nodular regenerative hyperplasia have been mistaken for cirrhosis or even metastatic carcinoma.

Nodular sinusoidal lymphocytes in Felty’s syndrome • Image donated by: Professor Ian Lauder Donor

Nodular sinusoidal lymphocytes in Felty’s syndrome • Image donated by: Professor Ian Lauder Donor organization: Leicester University, Department of Pathology

Management • The best treatment for Felty’s syndrome is to control underlying rheumatoid arthritis.

Management • The best treatment for Felty’s syndrome is to control underlying rheumatoid arthritis. Immunosuppresive therapy ( high doses of corticosteroids, Methotrexate, gold salts ) • The potential for leukopenia limits the use of cyclophosphamids • Penicillamine is bieng used less frequenty for RA because of its side effect profile. • Etanercept and infliximab are 2 newer agents prescribed for RA. These agents effects of tumor necrosis factor-alfa (TNF- ). These drugs are very effective in the treatement and control of RA

 • Intravenous immunoglobulin does not show reproducibly success. • Recombinant granulopoietic growth factors

• Intravenous immunoglobulin does not show reproducibly success. • Recombinant granulopoietic growth factors , such as granulocyte colony-stimulating factor (G-CSF) and granulocyte-monocyte colony- stimulating factor (GMCSF, effectively and quickly raise the granulocyte count, which is important for the patients with life threatening infections • Splenectomy is only recommended for patients with severe , intractable disease who exhibit no improvement with medical therapy and suffering fro recurrent or serious infection

 • Though Felty’s syndrome appears to be rare in rheumatoid arthritis patients, a

• Though Felty’s syndrome appears to be rare in rheumatoid arthritis patients, a proper complete diagnosis should be done in all RA patients and proper control of the RA.